Please ensure Javascript is enabled for purposes of website accessibility

Altimmune raises $4.9 million from institutional investors (access required)

Altimmune Inc., a drug company based in Gaithersburg, has agreements to raise about $4.9 million before fees through a stock sale.

To purchase a reprint of this article, contact [email protected].